Cytokinetics Inc’s recent filing unveils that its Officer FADY MALIK acquired Company’s shares for reported $0.47 million on Jul 08 ’25. In the deal valued at $33.36 per share,14,000 shares were bought.
Then, Malik Fady Ibraham sold 2,000 shares, generating $67,520 in total proceeds. Upon selling the shares at $33.76, the EVP Research & Development now owns 140,610 shares.
Before that, Blum Robert I sold 5,000 shares. Cytokinetics Inc shares valued at $167,750 were divested by the President & CEO at a price of $33.55 per share. As a result of the transaction, Blum Robert I now holds 398,108 shares, worth roughly $14.73 million.
Barclays initiated its Cytokinetics Inc [CYTK] rating to an Overweight in a research note published on April 24, 2025; the price target was $55. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. Stifel began covering CYTK with “Buy” recommendation on January 22, 2025. RBC Capital Mkts started covering the stock on November 08, 2024. It rated CYTK as “an Outperform”.
Price Performance Review of CYTK
On Friday, Cytokinetics Inc [NASDAQ:CYTK] saw its stock jump 1.15% to $37.01. Over the last five days, the stock has gained 6.78%. Cytokinetics Inc shares have fallen nearly -32.54% since the year began. Nevertheless, the stocks have fallen -21.32% over the past one year. While a 52-week high of $61.38 was reached on 01/27/25, a 52-week low of $29.31 was recorded on 05/15/25.
Levels Of Support And Resistance For CYTK Stock
The 24-hour chart illustrates a support level at 36.17, which if violated will result in even more drops to 35.34. On the upside, there is a resistance level at 37.45. A further resistance level may holdings at 37.89.
How much short interest is there in Cytokinetics Inc?
A steep rise in short interest was recorded in Cytokinetics Inc stocks on 2025-06-13, dropping by -1.6 million shares to a total of 14.01 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 15.6 million shares. There was a decline of -11.41%, which implies that there is a negative sentiment for the stock.
